Drug Discovery

share

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the...

share

In an effort to improve health outcomes of people with type 2 diabetes, Geisinger and Boehringer Ingelheim, on behalf...

share

Amgen and Simcere Pharmaceutical Group announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars...

share

Champions Oncology, a company engaged in the development and sale of advanced technology solutions and products to personalize...

share

Teva Pharmaceutical Industries announced the launch of generic Axiron®1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the...

share

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene...

share

Biognosys announced that it has secured USD 5m funding from new and existing investors in an extended series C...

share

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S ,...